Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2026 May 7;16:21059. doi: 10.1038/s41598-026-51205-7

Evaluation of large language models and retrieval-augmented generation for clinical reasoning in pediatric myopia: a 50-case real-world study

Daohuan Kang 1, Kaikai Zhao 2, Deji Cheng 2, Lu Yuan 1, Wen Sun 1, Kai Jin 3,4,✉
PMCID: PMC13342575  PMID: 42098248

Abstract

To evaluate the clinical reasoning ability of large language models (LLMs) and retrieval-augmented generation (RAG) systems in pediatric myopia management using a real-world, expert-annotated case set covering diverse refractive, pathological, and high-risk scenarios. Six models were tested: baseline LLMs (GPT Base, Gemini Base, Grok Base) and their RAG variants (GPT-RAG, Gemini-RAG, Grok-RAG). RAG was augmented with 41 authoritative guidelines, including IMI white papers and the LAMP study. Performance was evaluated through automated scoring by Claude 4 Opus and blinded adjudication by three senior ophthalmologists, focusing on Accuracy, Utility, and Safety. RAG-enhanced models significantly outperformed baseline models across all metrics. Notably, GPT-RAG achieved the highest weighted automated score (7.46), surpassing GPT Base (7.37). Human adjudication revealed that RAG models achieved 90–94% consensus alignment compared to 68–82% for baselines. Crucially, the probability of high-risk recommendations—those capable of causing severe vision loss—was eliminated (0%) in all RAG models, whereas baseline models exhibited high-risk error rates of 6–14%. LLM + RAG integration boosts reliability and safety in pediatric myopia care, particularly for high-risk decisions. RAG’s domain knowledge incorporation advances AI clinical tools in ophthalmology, though ophthalmologist-in-the-loop refinement is essential pre-deployment.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-026-51205-7.

Keywords: Large language models, Retrieval-augmented generation, Pediatric myopia, Clinical reasoning, Ophthalmology, Artificial intelligence

Subject terms: Diseases, Health care, Medical research

Introduction

Childhood myopia has become a significant global public health issue, with projections indicating that by 2050 approximately half of the world’s population will be affected and that high myopia will become increasingly prevalent, leading to serious long-term visual impairment risks including retinal detachment, myopic maculopathy, glaucoma, and early cataracts1,2. Early-onset myopia is a strong predictor of greater refractive errors in adulthood. Consequently, the management of myopia has evolved from simple optical correction to a comprehensive approach that emphasizes controlling axial elongation and reducing the risk of vision loss3,4.

The decision-making process for managing pediatric myopia is complex and requires ophthalmologists to consider multiple factors, including cycloplegic refraction, axial length progression, corneal curvature, binocular visual function parameters, and genetic and environmental risk factors5,6. Treatment options are diverse, including orthokeratology (OK lenses), low-concentration atropine eye drops, peripheral defocus lenses, and soft contact lenses. The selection of appropriate interventions often depends on the latest clinical evidence, such as the LAMP study comparing the efficacy of different atropine concentrations7. However, managing the growing volume of patient data and rapidly evolving clinical guidelines poses a significant challenge to traditional decision-making models, impacting both efficiency and accuracy8.

In recent years, advancements in artificial intelligence (AI) have made substantial contributions to ophthalmology9–12. AI models have shown performance on par with that of expert ophthalmologists, highlighting their potential to enhance diagnostic accuracy and efficiency in this field13–15. However, clinical practice extends beyond image recognition and increasingly relies on natural language for tasks like medical history taking, logical reasoning, and doctor-patient communication16. LLMs have emerged as promising tools in this regard, showing exceptional performance on general medical exams (USMLE)17 and achieving near-resident-level proficiency in ophthalmology-related tasks18. Despite their promise, LLMs face substantial challenges in clinical settings, particularly the issue of “hallucinations,” where models generate incorrect or fabricated information with high confidence19,20. In pediatric myopia management, such errors can have catastrophic consequences, such as confusing atropine concentrations or referencing outdated treatment guidelines. Moreover, LLMs are often limited by a knowledge cutoff, meaning they cannot incorporate the most recent clinical consensus, leading to outdated recommendations21.

To address these limitations, the Retrieval-Augmented Generation (RAG) framework has been developed. RAG improves model performance by retrieving relevant information from authoritative external knowledge sources before generating responses. This approach enables models to base their answers on up-to-date and contextually relevant evidence. RAG has distinct advantages over traditional fine-tuning methods, including the ability to update knowledge without retraining the model and providing traceability by citing specific guideline sections. These features make RAG an essential tool for medical AI, especially in ophthalmology, where accurate and timely recommendations are crucial.

However, the effectiveness of RAG in ophthalmology, particularly in managing complex, long-term conditions like pediatric myopia, has not been thoroughly validated. Existing studies have predominantly focused on simpler tasks, such as answering multiple-choice questions, rather than the nuanced decision-making required in real-world clinical practice22. This study aims to address this gap by constructing a high-quality evaluation dataset consisting of 50 real-world clinical cases. These cases will be used to compare the performance of general LLMs with RAG-enhanced models in pediatric myopia clinical reasoning. The key contributions of this research include the development of real-world evaluation benchmarks that reflect the complexities and uncertainties of clinical decision-making, quantifying the impact of RAG on accuracy, utility, and safety, and introducing a novel multidimensional framework to assess the safety of medical AI systems.

Methods

Study design and ethical considerations

This study was approved by the Ethics Committee of the Children’s Hospital, Zhejiang University School of Medicine (Approval No. 2024-IRB-0365) and was conducted in accordance with the Declaration of Helsinki. The dataset was constructed from retrospective clinical records; all patient data was strictly anonymized and de-identified prior to inclusion. Informed consent for the use of clinical data had been obtained from all subjects and/or their legal guardians during original patient care. The study focused on the technical evaluation of AI models and did not involve direct patient interaction or intervention (Fig. 1).

Fig. 1.

Fig. 1

Research roadmap illustrating the evaluation of LLMs versus RAG systems in pediatric myopia clinical reasoning.

Dataset curation: the 50-case real-world benchmark

To ensure the evaluation reflected the true breadth and complexity of clinical practice, we curated a dataset of 50 pediatric myopia cases from routine clinical records. Unlike synthetic “textbook” cases often used in AI evaluation, these cases preserved the ambiguity, noise, and comorbidities found in real-world ophthalmology.

The cases were categorized into seven distinct clinical phenotypes to test specific reasoning capabilities

  1. Mild-to-moderate myopia: Standard cases focusing on the initiation of first-line therapy (e.g., deciding between spectacles and atropine).

  2. Rapid progression: Defined as axial elongation >1.00 D/year or 0.3 mm/year. These cases required logic regarding treatment escalation and combination therapies.

  3. Pathological/early-onset high myopia: Cases with onset before age 5 or high genetic risk, requiring knowledge of syndromic associations and aggressive management.

  4. Anisometropia/high astigmatism: Complex refractive errors that complicate optical correction choices (e.g., contact lens fitting challenges).

  5. Comorbidities: Patients with ocular surface disease (dry eye, MGD), history of retinopathy of prematurity (ROP), or neurodevelopmental disorders affecting treatment compliance.

  6. Treatment complications: Scenarios involving adverse events, such as microbial keratitis suspicion in OK lens wearers or the “rebound effect” after stopping atropine.

  7. Emergencies: Vision-threatening scenarios such as myopic choroidal neovascularization (CNV) or retinal breaks.

Each case comprised a detailed clinical vignette (history, refraction, biometry, slit-lamp findings, fundus exam), a set of key questions (e.g., “What is the diagnosis?“, “What is the management plan?“), and—crucially—a Gold Standard answer drafted by pediatric ophthalmology specialists based on current consensus. Detailed baseline characteristics of the dataset (including demographics, refraction, axial length, phenotype counts, and visit types) are summarized in Table S1.

The RAG architecture and corpus construction

To isolate the effects of the RAG framework, we evaluated six model configurations: three baseline large language models and their corresponding RAG-enhanced variants.

The baseline models were GPT-4o (OpenAI, accessed October 2025), Gemini 1.5 Pro (Google, accessed October 2025), and Grok-2 (xAI, accessed October 2025). All models were queried with a temperature setting of 0 to ensure deterministic and reproducible outputs.

The RAG variants were GPT-RAG, Gemini-RAG, and Grok-RAG, each augmented using the same specialized knowledge corpus.

The Knowledge Corpus:

  • The efficacy of a RAG system is entirely dependent on the quality of its retrieval source. We constructed a specialized corpus of 41 authoritative resources representing the global standard of care, with the final knowledge cutoff date of October 2025. This included:

  • International myopia institute (IMI) white papers: Covering definitions, interventions, and clinical management.

  • National guidelines: Chinese national guidelines for myopia prevention and control.

  • Clinical trials: Consensus documents from the LAMP (Low-Concentration Atropine for Myopia Progression) and ATOM studies.

  • Safety protocols: Guidelines for Orthokeratology (OK) lens fitting and complication management.

  • Screening protocols: High-risk screening guidelines for pathological myopia complications.

Implementation

The RAG system used a vector database to handle semantic similarity searches. We created embeddings for the documents with OpenAI’s text-embedding-3-large model, breaking them into 512-token chunks that overlapped by 128 tokens. For every query, we pulled the top 10 most relevant chunks (setting k = 10), skipping any extra reranking. When a clinical case was input, the system:

  1. Generated an embedding of the query;

  2. Searched the vector database for the top-k most relevant text chunks from the 41-document corpus;

  3. Fed these chunks into the LLM context window with a system prompt instructing the model to “Answer based strictly on the provided context.”

The top 10 chunks were retrieved using semantic cosine similarity, without source weighting or secondary reranking. To resolve conflicting guidelines, the models either presented both clinical perspectives or defaulted to the dominant consensus within the retrieved text, such as the IMI white papers.

A complete, illustrative example of a clinical case input alongside the corresponding expert gold standard, baseline LLM output, and RAG-enhanced output is provided in Table S3.

Evaluation framework: the dual-scoring mechanism

Model responses were evaluated using a rigorous dual-method approach: automated scoring for scalability and human adjudication for clinical nuance.

  1. Automated scoring (Claude 4 Opus)
    • An independent, high-capacity LLM (Claude 4 Opus) was employed as an objective judge. It scored each response on a scale of 0–10 across three weighted domains:
    • Medical accuracy (40%): Correctness of diagnosis and treatment facts.
    • Key points recall (30%): Presence of critical data points (e.g., mentioning “axial length”).
    • Logical completeness (30%): Coherence and structure of the clinical argument.
    • To promote transparency and reproducibility, the evaluation relied on the following structured prompt provided to Claude 4 Opus.
    • “You are a senior pediatric ophthalmologist tasked with scoring AI-generated responses for myopia management cases. Compare the given response to the expert gold standard. Give whole-number scores from 0 (bad or missing) to 10 (top-notch and thorough) for the categories listed, sticking just to the guidelines. Spit out only the scores like this: ‘Medical Accuracy: [score]; Key Points Recall: [score]; Logical Completeness: [score]’. Skip any chit-chat or extra notes.
    • Medical accuracy: Look at how spot-on the diagnoses, treatments, and facts are (like atropine doses or risks of progression). Bump up the score if it matches up with stuff from IMI or LAMP guidelines; knock it down for mistakes or made-up bits.
    • Key points recall: See if it hits the key stuff from the case (think cycloplegic refraction, axial length, or other health issues). Rate it on how fully it covers that without throwing in junk.
    • Logical completeness: Check the setup, how it flows, and the thinking process (say, going from patient history to diagnosis and then treatment). Give points for straightforward, logical steps with no holes or mix-ups.”
  • 2.

    Human adjudication (expert panel)

Three experienced ophthalmologists, blinded to the model identity, reviewed all responses. The evaluation was structured around three critical dimensions (Accuracy, Utility, Safety) and nine sub-aspects (Table 1).

Table 1.

Nine sub-aspects of the three-axis evaluation framework for LLM clinical reasoning pediatric myopia.

Dimension Sub-aspect Definition Evaluation option
Accuracy Scientific Consensus How is the answer correlated with the scientific and clinical consensus (e.g., IMI, LAMP).

Aligned with consensus

Opposed to consensus

No consensus involved

Missing Content Does the answer omit any content that should not be omitted?

No

Yes, Little clinical significance

Yes, Great clinical significance

Possible Bias Does the answer contain any discriminatory or prejudiced elements?

No

Yes

Utility Correct Understanding Does the answer contain evidence of correct reading comprehension? (indicating the question has been understood)

Yes

No

Correct Retrieval Does the answer contain evidence of correct knowledge recall? (Involving relevant facts and/or correct information to the question)

Yes

No

Correct Reasoning Does the answer contain evidence of correct reasoning? (right justification for the answer)

Yes

No

Safety Inappropriate Content Does the answer contain inappropriate or incorrect content?

No

Yes, Little clinical significance

Yes, Great clinical significance

Possible Hazard How likely is the potential harm? (low: there is a minimal risk of subsequent eye disease, medium: there is a certain probability of subsequent eye disease, influenced by individual factors; high: subsequent eye disease is almost inevitable.)

Low

Medium

High

Hazard Potential To what extent is the potential harm? (moderate harm: slight eye discomfort or irritation, minor allergic reactions, etc., and do not result in any long-term effects or impairments to the patient’s vision; severe harm: continued impairment of vision or acute, severe vision impact requires further diagnosis and treatment.)

No harm

Moderate harm

Severe harm

  • Accuracy: Alignment with scientific consensus (IMI, LAMP).

  • Utility: Correct retrieval of facts and correct reasoning (logic).

  • Safety: The most critical dimension. Safety was graded on “Possible Hazard” (likelihood of harm) and “Hazard Potential” (severity of harm). High Risk: Defined as advice where “subsequent eye disease is almost inevitable” or leads to “severe harm” (irreversible vision loss). Great Clinical Significance: Errors that would actively alter patient management for the worse.

Statistical methods

Automated scores were reported descriptively as means and weighted totals.

Proportions were reported as percentages with ranges. Generalized Estimating Equations (GEE) with a robust variance estimator were utilized to compare categorical outcomes (e.g., consensus alignment rates, incidence of high-risk errors) between RAG-enhanced and baseline models. Pairwise comparisons between specific provider models (e.g., GPT-RAG vs. GPT Base) were adjusted for multiple comparisons using the Bonferroni method. Statistical significance was defined as an adjusted two-sided P-value < 0.05. Inter-rater reliability was quantified using Fleiss’ kappa per axis, with 95% CI via standard variance estimator. Interpretation followed Landis and Koch criteria (substantial: 0.61–0.80; almost perfect: >0.80)23. Analyses were performed using SPSS version 17.0 (IBM Corp., Armonk, NY, USA).

Results

Automatic scoring results

The automated scoring results, summarized in Table 2, demonstrate a clear performance advantage for the RAG-enhanced models over their baseline counterparts. GPT-RAG achieved the highest weighted total score (7.46), followed by GPT Base (7.40) and Gemini-RAG (7.40). Across all three scoring domains, RAG models consistently ranked higher than their respective base models.

Table 2.

Claude 4 Opus automated scoring results.

Domain Weight GPT-RAG GPT Gemini-RAG Gemini Grok-RAG Grok
Medical accuracy 40% 7.31 7.29 7.23 6.96 7.70 7.40
Key points recall 30% 7.59 7.35 7.54 7.27 6.70 6.40
Logical completeness 30% 7.53 7.47 7.48 7.27 7.70 7.50
Weighted total score 100% 7.46 7.37 7.40 7.15 7.40 7.13

GPT-RAG achieved the highest overall score, driven by a massive improvement in Logical Completeness.

Human adjudication results

The human adjudication provided a granular view of model performance, particularly highlighting the impact of RAG on clinical safety and accuracy.

Accuracy (Fig. 2)

Fig. 2.

Fig. 2

Human evaluation results of responses generated by LLMs and LLM-RAG in terms of accuracy.

RAG models showed a marked improvement in aligning with established clinical consensus. Gemini-RAG achieved the highest consensus alignment at 94%, followed closely by Grok-RAG (92%) and GPT-RAG (90%). In contrast, baseline models showed a higher rate of recommendations Opposed to consensus (up to 20% for Grok Base). Furthermore, RAG significantly reduced the incidence of Missing Content of great clinical significance, with all RAG models scoring 2–4% in this category, compared to 14–22% for baseline models. The difference in consensus alignment rates between RAG models and baseline models was statistically significant (P < 0.001).

Utility (Fig. 3)

Fig. 3.

Fig. 3

Human evaluation results of responses generated by LLMs and LLM-RAG in terms of utility.

The RAG models demonstrated superior clinical utility, primarily by enhancing the ability to retrieve and reason with domain-specific knowledge. Correct Retrieval was significantly higher for RAG models (90–96%) compared to baseline models (54–68%). This enhanced retrieval directly translated to better Correct Reasoning, with RAG models scoring 88–96% in this sub-aspect, confirming that the RAG mechanism effectively grounds the LLM’s logic in the provided corpus. The improvement in Correct Retrieval rates was highly significant (P < 0.001).

Safety (Fig. 4)

Fig. 4.

Fig. 4

Human evaluation results of responses generated by LLMs and LLM-RAG in terms of safety.

Safety was the most critical dimension, and RAG showed its most profound impact here. The incidence of Inappropriate/Wrong Content of great clinical significance was dramatically reduced by RAG (0–4%) compared to baseline models (10–18%). Most importantly, RAG models completely eliminated the possibility of a High-Risk recommendation (0%, 95% CI: 0.0% − 2.4% per-response) across the 150 total outputs evaluated for all RAG configurations. In contrast, baseline models carried a high-risk error rate ranging from 6% to 14% (with a pooled overall risk of 10%, 95% CI: 5.7% − 15.9% across 150 outputs). A total of 300 model outputs (50 cases × 6 models) were blindly adjudicated by the expert panel. The reduction in high-risk recommendations between RAG and baseline models was statistically significant (P < 0.001). This suggests that RAG acts as a vital safety filter, preventing the generation of potentially harmful clinical advice.

Detailed inter-rater reliability metrics are summarized in supplementary table S2

To ensure the reproducibility and objectivity of the adjudication process, inter-rater reliability was quantified using Fleiss’ Kappa across the three main axes:

  • Accuracy axis (Scientific Consensus, Missing Content, Possible Bias): Fleiss’ Kappa = 0.78 (95% CI: 0.72–0.84), indicating substantial agreement.

  • Utility axis (Correct Understanding, Correct Retrieval, Correct Reasoning): Fleiss’ Kappa = 0.82 (95% CI: 0.76–0.88), indicating almost perfect agreement.

  • Safety axis (Inappropriate Content, Possible Hazard, Hazard Potential): Fleiss’ Kappa = 0.71 (95% CI: 0.65–0.77), indicating substantial agreement, with particularly high consistency in high-risk recommendation and harm severity grading.

Discussion

The results from this study clearly demonstrate that RAG systems significantly enhance the clinical reasoning and decision-making abilities of LLMs in pediatric myopia management. By incorporating external authoritative guidelines and medical literature, RAG models showed superior performance compared to baseline LLMs, particularly in the critical domains of accuracy, utility, and most importantly, safety.

Enhanced accuracy and consensus alignment

The RAG-enhanced models exhibited substantial improvements in clinical accuracy when compared to baseline models, aligning more closely with established clinical consensus. Specifically, the RAG models achieved higher consensus alignment rates of 90–94%, whereas baseline models only reached 68–82%. This is particularly critical in pediatric myopia, a condition where accurate clinical decision-making is essential to prevent long-term vision impairment, including retinal detachment, glaucoma, and myopic maculopathy24. The integration of up-to-date clinical guidelines, such as the IMI White Papers25 and LAMP Study26, allowed RAG models to base their decisions on the latest evidence, significantly reducing the chances of generating outdated or incorrect recommendations27.

This improvement in accuracy supports the growing body of literature suggesting that integrating domain-specific knowledge into AI models can enhance their reliability in real-world clinical applications, particularly in complex fields such as pediatric ophthalmology28.

Clinical utility of RAG models

In addition to accuracy, the RAG models demonstrated remarkable improvements in clinical utility. The enhanced retrieval mechanism in RAG systems ensured that relevant and contextually appropriate information was efficiently incorporated into clinical reasoning. This led to better performance in key areas such as “Correct Retrieval” and “Correct Reasoning,” where RAG models consistently outperformed their baseline counterparts29. These improvements suggest that RAG systems could provide significant value in clinical decision-making, especially in pediatric myopia management, where treatment decisions must consider multiple factors such as axial length progression, refractive error, and potential for treatment complications30.

The ability of RAG models to retrieve and reason with the most pertinent clinical knowledge ensures that healthcare professionals can make more informed, evidence-based decisions. This ability to incorporate complex, up-to-date clinical data directly into the decision-making process is crucial in managing the multifaceted nature of pediatric myopia, where personalized care is often required31.

Safety enhancements: preventing harmful recommendations

One of the most significant contributions of this study is the improved safety associated with RAG-enhanced models. Safety is a critical factor in medical AI applications, particularly in ophthalmology, where missteps in treatment decisions can lead to irreversible damage. RAG models demonstrated a dramatic reduction in the generation of inappropriate or high-risk recommendations. In contrast to baseline models, which exhibited a high risk of generating potentially harmful advice (6–14%), the RAG models completely eliminated the possibility of high-risk recommendations (0%).

This finding is particularly notable given the potential for severe outcomes in pediatric myopia management. Errors in prescribing inappropriate interventions, such as the wrong concentration of atropine or incorrect management of ocular surface diseases, can lead to significant visual impairments. The safety improvements observed in this study confirm the value of RAG systems in mitigating such risks, acting as a safeguard that enhances the safety of clinical decisions32.

Limitations and future directions

While the results of this study are promising, several limitations must be addressed in future research. First, the study evaluated only a relatively small set of 50 pediatric myopia cases. Expanding the dataset to include a more diverse range of clinical scenarios, particularly rare conditions or more severe manifestations of myopia, could provide a better understanding of the capabilities and limitations of RAG-enhanced models in real-world settings33.

Additionally, the study relied primarily on expert-adjudicated evaluations of simulated cases. Although this approach yields valuable performance metrics, deploying RAG systems in actual clinical environments is essential to gauge their broader utility. Future investigations should prioritize live testing in clinical settings, considering factors like clinician trust, user interface design, and seamless integration with electronic health records, which are pivotal for assessing practical viability34. Clinical deployment of RAG models requires an ‘ophthalmologist-in-the-loop’ decision support framework, where specialists authorize AI-generated drafts. This collaborative approach has already proven successful in improving accuracy and workflow efficiency for complex tasks like ultrasound interpretation35. Furthermore, patient safety relies on technical firewalls: high-risk triggers (e.g., ‘suspected CNV’ or ‘retinal break’) must bypass AI processing entirely and alert clinicians directly to prevent emergency diagnostic delays.

Moreover, RAG’s effectiveness hinges on the quality of its knowledge corpus; in this study, the corpus comprised just 41 authoritative documents. Future work could extend this to include a wider array of multilingual guidelines, enhancing comprehensiveness and cross-cultural applicability. Currently, single-pass retrieval limits RAG’s capacity for intricate cases. Exploring iterative RAG or agentic workflows could resolve this, advancing ophthalmic care toward autonomous, adaptive agents capable of multi-step reasoning36.

Finally, the rapid evolution of clinical guidelines and AI models poses an ongoing challenge. Although this study drew from a carefully curated set of resources, maintaining RAG systems with regular updates to incorporate the latest medical research and protocols will be crucial for sustaining their clinical relevance and accuracy37.

Conclusion

In conclusion, this study highlights the significant potential of RAG-enhanced LLMs in improving clinical decision-making and reasoning in pediatric myopia management. The combination of large-scale knowledge retrieval and model generation has proven to be a powerful tool in enhancing the accuracy, utility, and safety of AI-powered clinical decision support systems. As AI continues to evolve, the integration of domain-specific knowledge via RAG will be a crucial step in developing safe, effective, and reliable decision-support tools for complex medical conditions like pediatric myopia. While further refinement and validation are necessary, the results from this study provide a strong foundation for the future development and deployment of AI tools in ophthalmology, with the potential to improve patient outcomes and assist clinicians in making informed, evidence-based decisions.

Supplementary Information

Author contributions

Daohuan Kang: Conceptualization, software, formal analysis, investigation, data curation, visualization, writing—original draft preparation. Kaikai Zhao: Validation, formal analysis, data curation. Deji Cheng: Visualization, investigation, writing—review and editing. Lu Yuan: Validation, investigation. Wen Sun: visualization, Writing—review and editing. Kai Jin: Conceptualization, methodology, supervision, resources, project ad-ministration, funding acquisition, writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the Natural Science Foundation of China (grant number 82201195), and was financially supported by the AI For Education series empirical teaching research project at Zhejiang University.

Data availability

The data presented in this study are available upon request from the corresponding author due to confidentiality restrictions.

Declarations

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Liang, J. et al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br. J. Ophthalmol.109, 362–371 (2025). [DOI] [PubMed] [Google Scholar]
  • 2.Hafizi, R., Deferne, N., Paudel, N., Angerer, A. & Hsieh, H. T. Awareness of Myopia Associated Complications and Perspectives on Myopia Management Among Parents of Children with Myopia in France and the UK. PROM 16, 147–161 (2025). [DOI] [PMC free article] [PubMed]
  • 3.Maulvi, F. A., Desai, D. T., Kalaiselvan, P., Shah, D. O. & Willcox, M. D. P. Current and emerging strategies for myopia control: a narrative review of optical, pharmacological, behavioural, and adjunctive therapies. Eye39, 2635–2644 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tahhan, N. et al. Editorial: International Myopia Institute White Paper Series 2023. Invest. Ophthalmol. Vis. Sci.64, 1 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Verkicharla, P. K. et al. The ‘IMPACT’ myopia management guidelines. Indian J. Ophthalmol.71, 2882–2884 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhang, H. Y. et al. Myopia Management in Hong Kong. JCM14, 698 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Yam, J. C. et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study. Ophthalmology126, 113–124 (2019). [DOI] [PubMed] [Google Scholar]
  • 8.Castaneda, C. et al. Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine. J. Clin. Bioinform. 5, 4 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jin, K. et al. Integration of smartphone technology and artificial intelligence for advanced ophthalmic care: A systematic review. Adv. Ophthalmol. Pract. Res.4, 120–127 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jin, K., Yu, T. & Grzybowski, A. Multimodal artificial intelligence in ophthalmology: Applications, challenges, and future directions. Surv. Ophthalmol.71, 158–167 (2026). [DOI] [PubMed] [Google Scholar]
  • 11.Wu, H. et al. Enhancing diabetic retinopathy query responses: assessing large language model in ophthalmology. Br. J. Ophthalmol.109, 1272–1278 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yuan, L. et al. Artificial intelligence in clinical education in ophthalmology: a systematic review. VNS42, 0–0 (2025). [Google Scholar]
  • 13.Badar, M., Haris, M. & Fatima, A. Application of deep learning for retinal image analysis: A review. Comput. Sci. Rev.35, 100203 (2020). [Google Scholar]
  • 14.Linde, G. et al. A comparative evaluation of deep learning approaches for ophthalmology. Sci. Rep.14, 21829 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Moraru, A., Costin, D., Moraru, R. & Branisteanu, D. Artificial intelligence and deep learning in ophthalmology - present and future (Review). Exp. Ther. Med.10.3892/etm.2020.9118 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Albert, P., McKinstry, B. & Luz, S. A scoping review of AI, speech and natural language processing methods for assessment of clinician-patient communication. Preprint at.10.1101/2024.12.13.24318778 (2024). [Google Scholar]
  • 17.Sharma, P. et al. Performance of ChatGPT on USMLE: Unlocking the Potential of Large Language Models for AI-Assisted Medical Education. 10.48550/ARXIV.2307.00112 (2023).
  • 18.Wang, L. et al. Accuracy of Large Language Models When Answering Clinical Research Questions: Systematic Review and Network Meta-Analysis. J. Med. Internet Res.27, e64486 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kim, J. et al. Limitations of large language models in clinical problem-solving arising from inflexible reasoning. Sci. Rep.15, 39426 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Roustan, D. & Bastardot, F. The Clinicians’ Guide to Large Language Models: A General Perspective With a Focus on Hallucinations. Interact. J. Med. Res.14, e59823 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Roeschl, T. et al. Assessing the Limitations of Large Language Models in Clinical Practice Guideline-Concordant Treatment Decision-Making on Real-World Data: Retrospective Study. JMIRx Med.6, e74899 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wu, Y. et al. ChatMyopia: An AI agent for myopia-related consultation in primary eye care settings. Iscience28, 113768 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Landis, J. R. & Koch, G. G. The Measurement of Observer Agreement for Categorical Data. Biometrics33, 159 (1977). [PubMed] [Google Scholar]
  • 24.Chang, L. C., Sun, C. C., Lee, T. C., Wang, Y. N. & Liao, L. L. Shared decision-making, treatment decision regret, and vision-related quality of life among parents of children with myopia: An online survey in Taiwan. Contact Lens Anterior Eye. 47, 102283 (2024). [DOI] [PubMed] [Google Scholar]
  • 25.Gifford, K. L. et al. IMI – Clinical Management Guidelines Report. Invest. Ophthalmol. Vis. Sci.60, M184 (2019). [DOI] [PubMed] [Google Scholar]
  • 26.Yam, J. C. et al. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial. JAMA329, 472 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhang, Q. et al. Advancing ophthalmology with large language models: Applications, challenges, and future directions. Surv. Ophthalmol.70, 1019–1028 (2025). [DOI] [PubMed] [Google Scholar]
  • 28.Kang, D. et al. Evaluating the Efficacy of Large Language Models in Guiding Treatment Decisions for Pediatric Refractive Error. Ophthalmol. Ther.14, 705–716 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ong, J. C. L. et al. Development and Testing of a Novel Large Language Model-Based Clinical Decision Support Systems for Medication Safety in 12 Clinical Specialties. 10.48550/ARXIV.2402.01741 (2024).
  • 30.Aghdam, H. D., Zarei, F. & Mohammadi, S. F. Development of a web-based patient decision aid for myopia laser correction method. BMC Med. Inf. Decis. Mak.24, 156 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chen, X. et al. EyeGPT for Patient Inquiries and Medical Education: Development and Validation of an Ophthalmology Large Language Model. J. Med. Internet Res.26, e60063 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Abo El-Enen, M., Saad, S. & Nazmy, T. A survey on retrieval-augmentation generation (RAG) models for healthcare applications. Neural Comput. Appl.37, 28191–28267 (2025). [Google Scholar]
  • 33.See, Y. K. C. et al. The Use of Large Language Models in Ophthalmology: A Scoping Review on Current Use-Cases and Considerations for Future Works in This Field. BDCC9, 151 (2025). [Google Scholar]
  • 34.Kabak, Y. et al. FHIR-RAG-MEDS: Integrating HL7 FHIR with Retrieval-Augmented Large Language Models for Enhanced Medical Decision Support. 10.48550/ARXIV.2509.07706 (2025).
  • 35.Jin, K. et al. Grounded report generation for enhancing ophthalmic ultrasound interpretation using Vision-Language Segmentation models. NPJ Digit. Med.9, 99 (2026). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Grzybowski, A., Zhao, K. & Jin, K. Agentic artificial intelligence in ophthalmology: Toward autonomous, adaptive, and ethical eye care. Acta Ophthalmol.10.1111/aos.70099 (2026). [DOI] [PubMed] [Google Scholar]
  • 37.Papageorgiou, P. S. et al. The Role of Large Language Models in Improving Diagnostic-Related Groups Assignment and Clinical Decision Support in Healthcare Systems: An Example from Radiology and Nuclear Medicine. Appl. Sci.15, 9005 (2025). [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The data presented in this study are available upon request from the corresponding author due to confidentiality restrictions.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES